Familiarity in the context of risk assessment of transgenic crops: focus on some countries in the Americas by CAPALBO, D. M. F. et al.
fbioe-07-00463 January 24, 2020 Time: 17:37 # 1
PERSPECTIVE
published: 28 January 2020
doi: 10.3389/fbioe.2019.00463
Edited by:
Joe Smith,
Adviser in Government, Science
and Regulation, Australia
Reviewed by:
Heidi Mitchell,
Office of the Gene Technology
Regulator, Department of Health,
Australian Government, Australia
Ulrich Ehlers,
Bundesamt für Verbraucherschutz
und Lebensmittelsicherheit (BVL),
Germany
*Correspondence:
Carmen Vicién
cvicien@gmail.com
Specialty section:
This article was submitted to
Biosafety and Biosecurity,
a section of the journal
Frontiers in Bioengineering and
Biotechnology
Received: 29 October 2019
Accepted: 19 December 2019
Published: 28 January 2020
Citation:
Capalbo DMF, Macdonald P,
Fernandes PMB, Rubinstein C and
Vicién C (2020) Familiarity
in the Context of Risk Assessment
of Transgenic Crops: Focus on Some
Countries in the Americas.
Front. Bioeng. Biotechnol. 7:463.
doi: 10.3389/fbioe.2019.00463
Familiarity in the Context of Risk
Assessment of Transgenic Crops:
Focus on Some Countries in the
Americas
Deise M. F. Capalbo1, Phil Macdonald2, Patricia Machado Bueno Fernandes3,
Clara Rubinstein4 and Carmen Vicién5*
1 Embrapa Environment and International Life Sciences Institute, São Paulo, Brazil, 2 Canadian Food Inspection Agency,
Ottawa, ON, Canada, 3 Federal University of Espírito Santo, Vitoria, Brazil, 4 Bayer Crop Science and International Life
Sciences Institute, Buenos Aires, Argentina, 5 University of Buenos Aires and International Life Sciences Institute,
Buenos Aires, Argentina
Problem formulation is the formal opening stage of a risk assessment that determines its
purpose and scope and hence guides the gathering of information data. The concepts
of familiarity and history of safe use are an integral part of problem formulation. These
concepts do not replace the case-by-case approach and are not taken as safety
standards but are valuable components of the process that shape the generation of
plausible, testable risk hypotheses. The International Life Sciences Institutes in Brazil
and Argentina have facilitated numerous discussions on the scientific principles for risk
assessment of transgenic crops in the Latin American region in the past 5–6 years.
The session held at ISBR 15th elaborated on the familiarity concept and derived tools
and their role in the evolution of risk evaluation criteria. Examples of how different
countries in the Americas interpret and apply these conceptual tools show that familiarity
is a valuable concept, although terms are very often confused and vaguely defined.
Formalizing these terms with clear definitions and scope of application in guidelines
and regulatory documents would reduce ambiguity, enhance predictability, and add
transparency to the evaluation processes.
Keywords: familiarity, history of safe use, risk assessment, problem formulation, regulatory framework,
harmonization
INTRODUCTION
Risk assessment criteria for transgenic organisms have been set decades ago and are still current,
built on the following: case-by-case, comparative assessment, tiered approach, and consideration
of the weight of evidence. However, as science moves forward, new developments and knowledge
make it necessary to periodically update and/or adjust these criteria (Borges et al., 2018).
Problem formulation has been defined as the “formal, structured, opening stage” of the risk
assessment (Patton, 1998). It was originally described in the Environmental Protection Agency’s
Framework Report (Norton et al., 1992; EPA, 2014) as a conceptual model that considers the values
to be protected, the data needed, and the analyses to be used. Problem formulation determines the
risk assessment purpose and scope, guiding the gathering of information and data. It presumes the
formulation of risk hypotheses, which in turn are shaped by previous experience and knowledge
and will be tested against available data (Wolt et al., 2010).
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The concepts of familiarity and history of safe use (HOSU)
are an integral part of problem formulation, as the availability
of existing information is a critical element that adds to the
weight of evidence. The Organisation for Economic Co-operation
and Development (OECD) was among the first to articulate
some of the core principles of familiarity for environmental risk
assessment of genetic modified organisms (GMOs) in the Blue
Book, back in 1986 (OECD, 1986); and later (OECD, 1993),
the basic principles for environmental risk assessment were
consolidated and globally accepted to this day. Regarding the food
and feed safety assessment of GMOs, the Codex Alimentarius
issued specific principles a decade later that constitute the global
standard reference (Codex Alimentarius, 2003).
The concept of familiarity involves knowledge and experience
that can be used for risk analysis and helps to identify if and
what additional knowledge is really needed; therefore, it is not
equivalent to safety (Constable et al., 2007).
In September 2018, a workshop facilitated by the International
Life Sciences Institutes in Argentina and Brazil discussed the
practice of the risk assessment of GMOs in Latin America
and identified that the terms “familiarity” and “HOSU” were
not clearly defined or were not consolidated as a concept
in the literature or guidelines. This group concluded that a
consensus would be required on these terms as important
tools with harmonization potential for regulatory criteria (ILSI
Brasil, 2018). The interpretation and practical implications of the
use of these terms by risk assessors in other countries of the
Americas were recognized as very relevant. The United States
Department of Agriculture (USDA) Animal and Plant Health
Inspection Service (APHIS) guideline for “extensions” (USDA-
APHIS, 2016), as well as the Canadian approach to similar
plants with novel traits (PNTs) (Canada/CFIA, 2018) are
excellent examples of how experience with risk assessment and
accumulated knowledge can be leveraged to enhance efficiency
while keeping a high regulatory standard.
A CAST publication from the same year (Council for
Agricultural Science and Technology [CAST], 2018) also
addressed familiarity as a key element to reduce the time and
effort for decision making and be more efficient in the use
of public resources. The following quote gives the flavor of
the discussion: “Regulatory agencies. . .should be prepared to
focus questions on identifying new pathways to risk assessment
endpoints associated with products that are unfamiliar and that
require more complex risk assessments.”
Based on these precedents, ILSI Argentina and Brazil held a
session at ISBR 15th (April 2019) to elaborate on the familiarity
concept and derived tools, and their role in the evolution of
risk evaluation criteria. Examples of how different countries in
the Americas interpret and apply these conceptual tools were
discussed and are presented here.
FAMILIARITY IN THE CONTEXT OF
PROBLEM FORMULATION
Data to support problem formulation can be derived
from multiple sources; for the case of transgenic crops,
published literature on the biology of the crop, genes, and
expression products, and existing documentation on molecular,
compositional, and agronomic/phenotypic data are all relevant
sources. This information is often available and can help
refine and/or reduce the hypotheses that need to be tested
for risk characterization (Garcia-Alonso, 2010). In this way,
the study plan will include only those tests that must be
conducted, as indicated by the problem formulation exercise
(Romeis et al., 2009).
By definition, “familiarity” (knowledge and experience)
helps in addressing uncertainty in the risk assessment
because it is based on preexisting knowledge, experimental
evidence, and experience gained over time (OECD, 1993;
Hokanson et al., 1999).
Three main knowledge-based factors have driven the
evolution of risk assessment criteria for transgenic crops in many
parts of the world during the last decade, namely, advances
in the knowledge of the intrinsic plasticity of plant genomes
(Doebley et al., 2006; Weber et al., 2012; Anderson et al., 2016),
of the genomic/genetic effects of transgenesis compared to
conventional breeding (Baudo et al., 2006; Batista et al., 2008),
and of the natural variability of biochemical composition of
the most important crop plants (OECD, 2006, 2002-2012;
Ricroch, 2012; Venkatesh et al., 2014; CERA, 2015). This body of
knowledge, along with extensive data from the characterization
of transgenic events, plus the experience of use of transgenesis
in plant breeding, has greatly increased the level of familiarity
with the technology (Burachik, 2010; Schnell et al., 2014;
Beker et al., 2016).
Experience with the practice of risk assessment is also in
itself a substantial component of familiarity, as experienced risk
assessors will integrate scientific advances to their own risk
assessment experience, contributing to the evolution of evidence-
based criteria (USDA-APHIS, 2018).
As for the term “HOSU,” a high level of ambiguity can be found
in the language used in guidelines or international documents.
According to the OECD, “A long HOSU is a reassuring and
practical starting point, for evaluating the safety of a novel food”
(OECD, 1999), although “long” is not defined. Similarly, vague
language is found in regulatory guidelines: “A substance may
be considered to have a HOSU as a food if it has been an
ongoing part of the diet for a number of generations in a large,
genetically diverse human population where it has been used in
ways and at levels that are similar to those expected or intended
in Canada” (Health Canada, 2006), or “related, among others,
with consumption habits and the massive consumption of the
GMO in other countries over years” (Ministerio de Agricultura
Ganadería y Pesca, 2013). Specific dates are also found as defining
HOSU: Europe defines novel foods as “any food that was not
used for human consumption to a significant degree within the
Union before 15 May 1997,” or, for traditional foods from third
countries, “foods should have been consumed in at least one third
country for at least 25 years as a part of the customary diet of a
significant number of people” (Engel et al., 2011; EU, 2015).
Although HOSU and familiarity are related concepts, these
are not synonymous, even when these terms are frequently used
interchangeably. HOSU should be preferably used for traditional
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uses, of which scientific procedures or formal knowledge would
not necessarily be available or may be limited. Familiarity, on
the other hand, refers to the body of knowledge (evidence/data)
and experience (of use, but also with risk assessment) with
technologies and products that have undergone a risk assessment
process or for which substantial data are available (Figure 1).
Ambiguous language can create confusion and ultimately leads to
discretionary interpretations and less predictable risk assessment
processes (Wasmer, 2019). To exemplify the relevance of clear
definitions, in the specific case of transgenic comparators for
field studies, using HOSU as an acceptance criterion would be
discretional. Familiarity, on the other hand, would describe the
availability of documented knowledge that would allow for using
these, as well as null segregants as suitable comparators.
Clear and consistent definitions enhance transparency and
facilitate conceptual harmonization for modern, evidence-based
risk assessments.
THE USE OF FAMILIARITY AND A
HISTORY OF SAFE USE IN THE
DECISIONS OF THE BRAZILIAN
NATIONAL BIOSAFETY TECHNICAL
COMMISSION
The current GMO legislation in Brazil centers around the
Biosafety Law and Decree (BRASIL, 2005), and Norms and
Technical decisions1 issued by the National Biosafety Technical
Commission (CTNBio).
The heart of the Brazilian GMO Biosafety policy is CTNBio2, a
consulting and deliberating multidisciplinary collegiate body that
formulates the norms, examines the evidence, and authorizes any
activity related to GMOs.
Even though neither the Biosafety Law and Decree nor
CTNBio’s Normative Resolutions mention the terms “familiarity”
or “HOSU” in the context of risk assessment of GMOs
and their by-products, these concepts are implicit in the
assessments performed by its members. As experienced scientists
(all members of CTNBio must hold a doctorate degree, have
acknowledged technical competence, and should have been
professionally active in the biosafety, biotechnology, biology,
human or animal health areas, and the environment), the use of
the scientific method is an intrinsic part of their analysis.
In fact, observing the many review processes held for the
commercial release of GMOs in the last 20 years3, we note the
use of the terms “history of use,” “safe use,” “safe consumption,”
“safe history,” and “HOSU” in several documents. However, the
term “familiarity” is not used. We believe that this is due to a lack
of a standard definition and therefore of a misconception of the
term. CTNBio’s risk assessors, in writing their technical opinions,
infer that there is knowledge (evidence/data) and experience in
the use of technologies and products, in particular, those who
1Available at: http://ctnbio.mcti.gov.br/resolucoes-normativas/
2Available at: http://ctnbio.mcti.gov.br/inicio
3Available at: http://ctnbio.mcti.gov.br/en/liberacao-comercial#/liberacao-
comercial/consultar-processo
have undergone a risk assessment process or for which substantial
data are available, in other words, familiarity.
The Brazilian Biosafety Law establishes that all activities
related to GMOs in the country must be “guided by the
drive for attaining scientific development in the biosafety and
biotechnology area, the protection of life and human beings, of
animal and plant health, and the compliance with the principle of
environmental precaution.” In addition, it is the responsibility of
the proponent to establish that the proposed activity will not (or
is very unlikely to) result in significant harm.
Normative Resolution No. 05 of CTNBio (BRASIL, 2007)
mentions “the history of use for food and feed of the GMO
unmodified parent” and “the history of cultivation and usage
of the GMO unmodified parent in the environment” as
key pieces of information to consider. In addition, CTNBio
Technical Decisions have consistently reflected (even with
no mention in the law) the application of conceptual tools
based on familiarity, as data for human and animal health
risk assessment performed in other parts of the world are
considered. However, as established in the same normative,
environmental evidence for risk assessment has to be
generated in the ecosystems in which the particular plant
will be cultivated.
National Biosafety Technical Commission has evaluated
and approved four yeast strains for the production of
first- and second-generation ethanol, three yeast strains,
and seven microalgae for oil production, in addition to a
large quantity of animal vaccines, until 2018. Recently, four
varieties of GM corn have been approved for marketing
exclusively for human and animal consumption, although
they cannot be grown in Brazil because they have not
been tested in the Brazilian edaphoclimatic conditions as
required; however, these assessments did consider available
information generated elsewhere, and therefore, the concept of
familiarity was used.
Finally, as stated in the Brazilian Biosafety Law: “CTNBio
shall monitor the development and technical-scientific progress
attained by the biosafety, biotechnology, bioethics and related
areas, with aims at increasing their capacity of protecting human,
animal and plant health and the environment.” This provision
legally ensures that CTNBio’s decisions are based on the most
current scientific knowledge and state of the art.
THE REGULATION OF AGRICULTURAL
BIOTECHNOLOGY AND SCIENCE: A
CANADIAN PERSPECTIVE ON THE
CONCEPTUAL TOOLS FOR PROBLEM
FORMULATION
During the scientific consultations carried out in the late 1980s
on biotechnology-derived plants, it was agreed that the regulatory
scope should be focused on plants with traits sufficiently different
from those already present in the species, as to require a
risk assessment. This led to the recommendation that the
product and not the process would be regulated, and the
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FIGURE 1 | Proposed differences between HOSU and Familiarity.
scientific perspective that came from these consultations was that
plants derived through genetic engineering were not necessarily
any riskier than those derived through chemical mutagenesis
or other breeding techniques. This resulted in a regulatory
approach that created the basis for the effective incorporation
of science into policy, giving rise to the articulation of the
1993 Federal Regulatory Framework for Biotechnology4. This
framework described an approach to biotechnology, based on the
use of science-based safety assessments and risk management,
aimed at protecting human and animal health, and the
environment and at the same time providing an environment
that allowed for innovation. All current regulatory frameworks
for transgenic plants incorporate the need for a risk assessment
prior to environmental release, to identify and evaluate the risks
associated with the release and cultivation of these plants using a
comparative approach.
Key to the environmental risk assessment is a thorough
knowledge of the crop species that has been subject to
modification by biotechnology to express a new trait. This
knowledge is fundamental to conducting a comparative risk
assessment. The concept of familiarity is used to identify
and evaluate environmental risks that may be associated with
the release of a transgenic plant and to inform management
practices that may be needed to mitigate recognized risks.
In Canada, this requirement is satisfied by the creation of
individual-crop biology documents. These documents describe
the behavior of the crop species specifically in the Canadian
environment and include a description of relevant parameters
(plant growth, reproduction, interactions with related and
4Available at: https://www.ourcommons.ca/Content/Archives/Committee/352/
sust/reports/03_1996-11/chap2-e.html
unrelated species, management practices, etc.) to inform the
risk assessment (CFIA, 2017). Although similar in focus to
the consensus documents developed by the OECD (2006),
the Canadian document describes management conditions
and environmental interactions for the unmodified species
that are specific to the Canadian environment, and uses
the familiarity with the cultivation and management of a
species as the basis to identify potential hazards during the
safety assessment.
Using familiarity as a guiding principle and considering
pathways to harm, a hypothesis that growing a certain GM crop
will cause no harm is really a hypothesis that growing the GM
crop will cause no greater harm than that cultivation of the non-
GM crop it may replace. For the risk assessment, “a hypothesis
that growing a certain GM crop will pose no unacceptable risk is
really a hypothesis that any increase in risk caused by growing the
GM crop will be acceptable” (Raybould and Macdonald, 2018).
The principles of the comparative risk assessment, the
use of familiarity, and the Canadian product-based approach
(CFIA, 2017) were evident in a recent incident when Canadian
regulators, like those in other countries, became aware that
petunias that had been genetically engineered to produce
orange flowers by using a gene from corn were potentially
present in Canada. Regulators in Canada considered relevant
information and scientific rationale, and determined that the
GM petunias pose no more risk to the environment than
conventional petunias, and in line with the product-based
approach, they would not be regulated in Canada. Since
there was no scientific evidence that the GM petunias posed
any risk to the environment, distributors or producers of
the GM petunias were not required to remove them from
the supply chain.
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For the crops we know well, the concept of familiarity and
the comparative risk assessment approach has provided a useful
paradigm for risk assessments. In fact, today most of the maize,
soybeans, and canola grown by Canadian farmers are a product
of biotechnology. As techniques such as gene editing push more
new varieties forward to the marketplace, these sound principles
for risk assessment, anchored in a strong policy framework, will
allow Canadian farmers safe access to these new varieties.
CONCEPTUAL TOOLS BASED ON
FAMILIARITY. TRANSPORTABILITY OF
FIELD STUDIES FROM BRAZIL TO
ARGENTINA: A CASE STUDY
The conceptual framework for data transportability (DT)
builds on the premise that results from well-designed studies
conducted for the environmental and food/feed risk assessment
of transgenic crops may be relevant and therefore transportable
to other geographies (Garcia-Alonso et al., 2013). This concept
focuses not only on methodological quality but also on the
familiarity with crops, traits, and receiving environments.
Bean crop (Phaseolus vulgaris) production took relevance in
Argentina in the 70s as an alternative for rotation with other
crops. One of the main diseases causing important yield losses
is golden mosaic, caused by the Bean Golden mosaic virus
(BGMV). In 2011, a transgenic bean resistant to BGMV was
approved in Brazil for cultivation and consumption, developed
by EMBRAPA (Brazilian Agricultural Research Company),
through an RNA interference mechanism (BRASIL, 2011). ILSI
Argentina’s Biotechnology Working Group was interested in
testing the applicability of the framework to a real case and,
to this end, convened a subteam to discuss this particular
case as an example.
A set of regulatory field studies carried out by EMBRAPA
in Brazil were reviewed to discuss their transportability to the
argentine receiving environment. This discussion considered
that information generated in field trials is transportable,
provided that trials are properly designed and conducted in
diverse agroclimatic environments, allowing for the expression
of any biologically relevant phenotypic differences. Under these
considerations, sites selection, methodologies, and agronomic
management of the studies were examined with focus on protocol
and end point consistency, record keeping, and traceability.
Familiarity with the crop and the bean cultivation zones in
Argentina was also considered. The group concluded that
the trials were transportable from Brazil to Argentina and
might be eventually applicable to a risk evaluation process,
provided that assessment end points would respond to the
risk hypotheses identified according to regulatory requirements
(Vesprini et al., 2019).
CONCLUSION
The concepts of familiarity and HOSU are an integral part
of problem formulation. Although related concepts, they
are not synonymous, in spite of the fact that they are
often used interchangeably. Ambiguous language leads
to discretionary interpretations and less predictable risk
assessment processes. Clear and consistent definitions
are needed to enhance transparency and facilitate
conceptual harmonization for modern, evidence-based
risk assessments.
This document intents to highlight the need for clearer
definitions of these terms for the case of transgenic crops
and propose to differentiate both terms based on the
availability of documented knowledge. In this way, Familiarity
should refer to the body of knowledge and experience
with technologies and products that have undergone a
risk assessment process or for which substantial data are
available. HOSU, on the other hand, should be preferably
used for traditional uses, of which scientific procedures
or formal knowledge would not necessarily be available
or may be limited.
The continued commitment in the practice of risk
assessment of those who have direct responsibility for
regulatory oversight leads to the integration of scientific
advances in their own risk assessment experience, thus
contributing to the evolution of evidence-based criteria.
In other words, it allows for integrating familiarity into
regulatory decisions. Collaboration among regulatory agencies is
essential to this end.
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